- All sections
- C - Chemistrymetallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganismscompositions or test papers thereforprocesses of preparing such compositionscondition-responsive control in microbiological or enzymological processes
- C12Q 1/683 - Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
Patent holdings for IPC class C12Q 1/683
Total number of patents in this class: 234
10-year publication summary
|
13
|
10
|
32
|
37
|
36
|
24
|
23
|
31
|
20
|
11
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| 10X Genomics, Inc. | 1204 |
38 |
| Nucleix, Ltd. | 57 |
12 |
| Cascade Biosystems, Inc. | 27 |
10 |
| Bio-Rad Laboratories, Inc. | 1615 |
6 |
| The Regents of the University of California | 19898 |
5 |
| Cornell University | 3302 |
5 |
| Quest Diagnostics Investments LLC | 403 |
5 |
| The Board of Trustees of the Leland Stanford Junior University | 6402 |
4 |
| Suntory Holdings Limited | 2029 |
4 |
| Takara Bio Inc. | 237 |
4 |
| The University of North Carolina at Chapel Hill | 2031 |
4 |
| Gen-Probe Incorporated | 994 |
3 |
| Guardant Health, Inc. | 417 |
3 |
| Keygene N.V. | 265 |
3 |
| Roche Sequencing Solutions, Inc. | 647 |
3 |
| Seegene, Inc. | 396 |
3 |
| Sequenom, Inc. | 274 |
3 |
| Sherlock Biosciences, Inc. | 25 |
3 |
| Mammoth Biosciences, Inc. | 146 |
3 |
| Singlera Genomics, Inc. | 11 |
3 |
| Other owners | 110 |